17 related articles for article (PubMed ID: 37897879)
1. Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study).
Assié JB; Corre R; Levra MG; Calvet CY; Gaudin AF; Grumberg V; Jouaneton B; Cotté FE; Chouaïd C
Ther Adv Med Oncol; 2020; 12():1758835920967237. PubMed ID: 33403011
[TBL] [Abstract][Full Text] [Related]
2. Long-term survivors with immunotherapy in advanced NSCLC: is 'cure' within reach?
Monteverdi S; Vita E; Sartori G; Ferrara MG; D'Argento E; Tortora G; Milella M; Bria E; Pilotto S
Transl Cancer Res; 2020 Feb; 9(2):409-414. PubMed ID: 35117384
[No Abstract] [Full Text] [Related]
3. Surviving Incidentally Found Non-Small Cell Lung Cancer After Lung Transplantation.
Coster JN; Sanchez PG
Ann Thorac Surg; 2024 Jan; ():. PubMed ID: 38286203
[No Abstract] [Full Text] [Related]
4. Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.
Chouaïd C; Grumberg V; Batisse A; Corre R; Giaj Levra M; Gaudin AF; Prodel M; Lortet-Tieulent J; Assié JB; Cotté FE
JCO Clin Cancer Inform; 2022 Feb; 6():e2100108. PubMed ID: 35113656
[TBL] [Abstract][Full Text] [Related]
5. Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Figueiredo A; Almeida MA; Almodovar MT; Alves P; Araújo A; Araújo D; Barata F; Barradas L; Barroso A; Brito U; Camacho E; Canário D; Cardoso T; Chaves A; Costa L; Cunha J; Duarte J; Estevinho F; Felizardo M; Fernandes JP; Ferreira L; Ferreira L; Fidalgo P; Freitas C; Garrido P; Gil N; Hasmucrai D; Jesus E; Lopes JA; de Macedo JE; Meleiro A; Neveda R; Nogueira F; Pantorotto M; Parente B; Pego A; Rocha M; Roque J; Santos C; Saraiva J; Silva E; Silva S; Simões S; Soares M; Teixeira E; Timóteo T; Hespanhol V
Pulmonology; 2020; 26(1):10-17. PubMed ID: 31630986
[TBL] [Abstract][Full Text] [Related]
6. Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.
Debieuvre D; Juergens RA; Asselain B; Audigier-Valette C; Auliac JB; Barlesi F; Benoit N; Bombaron P; Butts CA; Dixmier A; Gröschel A; Gutz S; Labbé C; Moro-Sibilot D; Pérol M; Raspaud C; Schumann C; Juarez-Garcia A; Lakhdari K; Pettersson F; Penrod JR; Reynaud D; Waldenberger D; Allan V; Sebastian M
Lung Cancer; 2021 Jul; 157():40-47. PubMed ID: 33980420
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis.
Giaj Levra M; Cotté FE; Corre R; Calvet C; Gaudin AF; Penrod JR; Grumberg V; Jouaneton B; Jolivel R; Assié JB; Chouaïd C
Lung Cancer; 2020 Feb; 140():99-106. PubMed ID: 31911324
[TBL] [Abstract][Full Text] [Related]
8. Three-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of ONO-4538-05 and ONO-4538-06 studies.
Horinouchi H; Nishio M; Hida T; Nakagawa K; Sakai H; Nogami N; Atagi S; Takahashi T; Saka H; Takenoyama M; Katakami N; Tanaka H; Takeda K; Satouchi M; Isobe H; Maemondo M; Goto K; Hirashima T; Minato K; Sumiyoshi N; Tamura T
Cancer Med; 2019 Sep; 8(11):5183-5193. PubMed ID: 31353840
[TBL] [Abstract][Full Text] [Related]
9. Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis.
Assié JB; Grumberg V; Reynaud D; Gaudin AF; Batisse A; Jolivel R; Jouaneton B; Cotté FE; Chouaïd C
Respir Med Res; 2023 Nov; 84():101051. PubMed ID: 37897879
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
